Cardiol Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:CT9 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
26 Dec 24	Buy€20,856	Guillermo Torre-Amione	Individual	17,240	€1.21
19 Dec 24	Buy€23,817	Andrew Hamer	Individual	18,900	€1.26
18 Dec 24	Buy€27,038	Guillermo Torre-Amione	Individual	21,548	€1.38
17 Dec 24	Buy€12,970	Bernard Lim	Individual	10,000	€1.30
17 Dec 24	Buy€47,595	Peter Pekos	Individual	38,750	€1.23
16 Dec 24	Buy€50,210	David Elsley	Individual	40,000	€1.26
16 Dec 24	Buy€33,242	Christopher Waddick	Individual	25,900	€1.28
24 Jun 24	Buy€94,551	David Elsley	Individual	50,000	€1.89

Insider Trading Volume

Insider Buying: CT9 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CT9?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	15,005	0.0184%
Individual Insiders	3,866,442	4.74%
Institutions	5,109,414	6.26%
General Public	72,612,561	89%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 25.1%.

Top Shareholders

Top 25 shareholders own 10.6% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
2.17%	Tejara Capital Limited., Asset Management Arm	1,771,270	€2.2m	2.85%	1.13%
1.53%	David Elsley	1,244,500	€1.6m	3.32%	no data
1.43%	AdvisorShares Investments, LLC	1,170,869	€1.5m	-20.2%	0.24%
1.04%	Michael Willner	851,580	€1.1m	10.4%	no data
0.97%	MM Asset Management Inc	795,625	€1.0m	-13.9%	0.1%
0.62%	Peter Pekos	506,040	€640.5k	8.29%	no data
0.57%	Andrew Hamer	466,613	€590.6k	48.4%	no data
0.33%	Lion Street Advisors, LLC	273,281	€345.9k	7.9%	0.13%
0.32%	Guillermo Torre-Amione	259,309	€328.2k	17.6%	no data
0.2%	Foundations Investment Advisors LLC	161,950	€205.0k	237%	no data
0.17%	Colin Stott	142,500	€180.4k	0%	no data
0.17%	Christopher Waddick	135,900	€172.0k	23.6%	no data
0.15%	Teri Loxam	120,000	€151.9k	100%	no data
0.12%	Knoll Capital Management	100,000	€126.6k	0%	0.1%
0.12%	Jennifer Chao	100,000	€126.6k	0%	no data
0.12%	MGO One Seven LLC	100,000	€126.6k	0%	0.01%
0.078%	Morgan Stanley, Investment Banking and Brokerage Investments	63,700	€80.6k	133%	no data
0.075%	Cambridge Investment Research Advisors, Inc.	61,001	€77.2k	-47.5%	no data
0.071%	UBS Asset Management AG	57,650	€73.0k	0.26%	no data
0.067%	PMG Investment Solutions AG	55,000	€69.6k	0%	0.02%
0.064%	Geode Capital Management, LLC	52,435	€66.4k	0%	no data
0.061%	BMO Asset Management Corp.	50,000	€63.3k	-0.22%	no data
0.049%	Bernard Lim	40,000	€50.6k	33.3%	no data
0.045%	Marble Harbor Investment Counsel, LLC	36,900	€46.7k	0%	0.01%
0.044%	Goldman Sachs Group, Investment Banking and Securities Investments	36,100	€45.7k	53.6%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/30 04:42
End of Day Share Price	2024/12/30 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cardiol Therapeutics Inc. is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Edward Nash	Canaccord Genuity
Charles Duncan	Cantor Fitzgerald & Co.
Christian Orquera	First Berlin Equity Research GmbH